Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 September 2018 Photo Stephen Collett
Outstanding Alumni awarded
Attending the awards evening were from the left: Dr Mafu Rakometsi; Gustav Wilson; Dr Pieter du Toit, National Executive Alumni Chairperson; Ace Moloi; Dr Khotso Mokhele; Prof Dave Lubbe; Dr Suzanne Staples; Prof Francis Petersen; Bertus Jacobs, and Tshepo Moloi.

A medical doctor, an economist, an author, and experts in the fields of Information Technology, Education, Management and Sociology are the winners of this year’s Chancellor’s Distinguished Alumni Awards

This is the 36th year that the UFS honours those alumni who are not only flying the Kovsie flag high, but are inspiring excellence and transforming lives.

Chancellor’s Challenge

UFS Chancellor Dr Khotso Mokhele had a sobering message for those who attended the awards ceremony on 8 September. He shared how, on a recent visit to the US, he had a chance to visit the campus of Facebook in Seattle, and heard how every year Facebook received more than two million CVs from prospective employees – 98% of whom sported A-average grades. Management then confided in him that they never hired a CV, but rather a mindset.

“They sift through all those applications, looking for someone with a vision to disrupt the status quo,” Mokhele said. “This continent will be left behind if we don’t adopt that mindset – that confidence that borders on arrogance – that we can change the world. Are we ready for that challenge?” 

The recipients in the various categories are:

Chancellor's Distinguished Alumnus of the Year:       
Danie Meintjes – Former Group Chief Executive Officer of Mediclinic

Cum Laude Awards
Dr Mafu Rakometsi ¬ Chief Executive Officer of the Council for Quality Assurance in General and Further Education and Training (Umalusi)
Dr Suzanne Staples, Principal Investigator at the Tuberculosis & HIV Investigative Network (THINK)

Kovsie Ambassador Awards
Tshepo Moloi – Economist at the South African Reserve Bank
Bertus Jacobs – Chief Technology Officer at IoT.nxt
Gustav Wilson, Regional Head (Development and Care) Department of Correctional Services 

Executive Management Award

Prof Dave Lubbe – Research Fellow and Professor at UFS School of Accountancy.

Young Alumnus of the Year
Ace Moloi – Author and literary consultant

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept